Arcutis Biotherapeutics (ARQT) Assets & Liabilities 2020-2026

Total assets, cash, long-term debt, book value, and leverage ratios

Assets & Liabilities

Assets, cash, debt, book value, and leverage

Total Assets: $460.00M
Cash: $34.76M
Long-Term Debt: $101.47M
Book Value: $189.65M
D/E Ratio: 0.5
Debt/EBITDA: N/A

With $460.00M in assets and $101.47M in long-term debt, the D/E of 0.5and book value of $189.65M — shows a conservative capital structure — the company has a strong financial cushion to weather downturns.

Total Assets

Expanding asset base can indicate business growth

Cash & Equivalents

Shows liquidity available for opportunities or downturns

Long-Term Debt

Declining debt trend is generally positive

Book Value (Equity)

Growing book value signals intrinsic value creation

Debt / Equity

Lower means less reliance on borrowed money

Debt / EBITDA

Below 2x is conservative; above 4x is high